MedLife welcomes Hemovent GmbH in its network

hemovent

Hemovent GmbH, an emerging medical device Company located in Aachen, that announced last week that it has closed a $6 million Series A Investment, is MedLife’s youngest member. Hemovent is developing the world’s smallest and first self-contained and fully portable Extra Corporeal Membrane Oxygenation (ECMO) system that supports or replaces heart and lung function in the event of cardiac and respiratory failure. www.hemoventgmbh.com